The Centers for Medicare & Medicaid Services will keep its Medicare GLP-1 Bridge program in place through the end of 2027, letting eligible beneficiaries access drugs like Wegovy and Zepbound for a ...

"I've seen too many parents of friends and family find out their long-term care plans are basically useless." (Photo subject is a model.) I'd like to retire at 55. The only thing holding me back is ...

Welcome back to Diagnosis, a vertical focused on the intersection of healthcare policy and politics. — ‘Freedom’ battle — ...

The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...